Arezou Khosroshahi
0000-0001-8365-8497
Publication & Citation Trends
Publications
0 total
GS-002 Safety and efficacy of inebilizumab in IgG4 related disease in participants with pancreatic, biliary, and hepatic involvement: results from the phase 3 MITIGATE trial
Cited by 1
Semantic Scholar
POS0009 Early Onset and Durability of Efficacy in Inebilizumab-treated Participants with IgG4 Related Disease: Post Hoc Analyses from the Phase 3 MITIGATE Trial
Cited by 1
Semantic Scholar
625: SAFETY AND EFFICACY OF INEBILIZUMAB IN IGG4 RELATED DISEASE IN PARTICIPANTS WITH PANCREATIC AND BILIARY INVOLVEMENT: RESULTS FROM THE PHASE 3 MITIGATE TRIAL
Cited by 0
Semantic Scholar
Safety and efficacy of inebilizumab in IgG4 related disease in participants with pancreatic and biliary involvement: Results from the phase 3 mitigate trial
Cited by 0
Semantic Scholar
OP0189 SAFETY AND EFFICACY OF INEBILIZUMAB IN IgG4-RELATED DISEASE ACROSS VARIOUS PARTICIPANT DEMOGRAPHICS: SUBGROUP ANALYSIS FROM THE MITIGATE STUDY
Cited by 0
Semantic Scholar
Research Topics
IgG4-Related and Inflammatory Diseases
(48)
Neuroendocrine Tumor Research Advances
(29)
Gastrointestinal disorders and treatments
(25)
Systemic Lupus Erythematosus Research
(15)
COVID-19 Clinical Research Studies
(11)
Affiliations
Brigham and Women's Hospital
Massachusetts Eye and Ear Infirmary
Harvard University
Emory University
Emory and Henry College